Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information... Show more
FLGT is expected to report earnings to fall 37.93% to -36 cents per share on November 06
Q3'26
Est.
$-0.36
Q2'26
Missed
by $0.14
Q1'26
Missed
by $0.25
Q4'25
Beat
by $0.22
Q3'25
Beat
by $0.36
The last earnings report on July 30 showed earnings per share of -57 cents, missing the estimate of -43 cents. With 106.33K shares outstanding, the current market capitalization sits at 470.03M.